Table 3. Postoperative survival according to expression of VEGF-C in NSCLC.
|
Expression of VEGF-C in |
||||||
|---|---|---|---|---|---|---|
|
Stromal macrophages |
Tumour cells |
|||||
| Negative (%) | Positive (%) | P-value | Low (%) | High (%) | P-value | |
| All patients | 57.3 | 60.3 | 0.921 | 67.9 | 53.5 | 0.046 |
| Stratified with pathologic (p-) stage | ||||||
| p-Stage I | 61.1 | 74.3 | 0.246 | 76.0 | 65.5 | 0.231 |
| p-Stage II | 44.4 | 69.2 | 0.329 | 66.7 | 44.4 | 0.559 |
| p-Stage IIIA | 53.9 | 33.2 | 0.117 | 48.8 | 33.5 | 0.176 |
| Stratified with histologic type | ||||||
| Squamous cell | 49.9 | 63.4 | 0.656 | 70.7 | 48.3 | 0.056 |
| Adenocarcinoma | 58.5 | 56.1 | 0.613 | 64.2 | 53.7 | 0.291 |
Each figure shows the 5-year survival rate of the each patient group.